Aveanna Healthcare Q3 revenue beats; raises FY revenue forecast

Aveanna Healthcare Holdings

06/11/2025 11:44

Overview

Aveanna Q3 revenue grows 22.2% yr/yr, beating analyst expectations

Company reports Q3 net income of $14.1 mln, reversing prior year loss

Aveanna raises full-year 2025 revenue guidance to over $2.375 bln

Outlook

Aveanna raises full-year 2025 revenue guidance to over $2.375 bln from over $2.3 bln

Company increases full-year 2025 adjusted EBITDA guidance to over $300 mln from over $270 mln

Result Drivers

PDS SEGMENT GROWTH - Revenue increase primarily driven by $104.9 mln growth in PDS segment

STRATEGIC TRANSFORMATION - CEO Jeff Shaner attributes revenue and EBITDA growth to strategic transformation efforts

OPERATIONAL EXCELLENCE - CFO Matt Buckhalter highlights operational excellence and disciplined execution as drivers of improved results

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$621.90 mln
$592.22 mln (9 Analysts)
Q3 EPS
$0.06
Q3 Net Income
$14.10 mln
Q3 Adjusted EBITDA
$80.10 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $9.25, about 0.4% above its November 5 closing price of $9.21

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nGNX1QDt8X

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)